FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: ADVISORY COMMITTEE; ONCOLOGIC DRUGS ADVISORY COMMITTEE; RENEWAL

WASHINGTON, Aug. 21 -- Food and Drug Administration has issued a notice called: Advisory Committee; Oncologic Drugs Advisory Committee; Renewal.

The notice was published in the Federal Register on Aug. 21 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA) is announcing the renewal of the Oncologic Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Oncologic Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the September 1, 2028, expiration date.

For more information...